But Transforming growth factor β inducible protein (TGFBI), also known as BIGH3, upregulates the expression of HIF-1α by inhibiting the PI3K/AKT/mTOR signaling pathway, thereby promoting EMT and RCC cell proliferation (Zhan et al., 2024). This evidence concerns the gene TGFBI and renal cell adenocarcinoma.